This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US District Court: Eastern District of Tennessee - In re Skelaxin (Metaxalone) antitrust litigation [EPP partial summary judgment]

( August 30, 2013, 22:31 GMT | Official Statement) -- MLex Summary: End-payor plaintiffs have moved for partial summary judgment on defendants' 'pass-on affirmative defenses' that plaintiffs' claims are barred to the extent that they seek damages for any alleged overcharge plaintiffs passed on to other entities. EPPs argue they are at the end of the chain of distribution, do not sell Skelaxin or metaxalone, and thus cannot 'pass-on' any overcharge to others.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections